The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Yu.A. Shpilyukova

Research Center of Neurology

S.N. Illarioshkin

Research Center of Neurology

Oral disease-modifying therapy for adult patients with spinal muscular atrophy type 2

Authors:

Yu.A. Shpilyukova, S.N. Illarioshkin

More about the authors

Views: 1320

Downloaded: 60


To cite this article:

Shpilyukova YuA, Illarioshkin SN. Oral disease-modifying therapy for adult patients with spinal muscular atrophy type 2. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(12):148‑153. (In Russ., In Engl.)
https://doi.org/10.17116/jnevro2023123121148

Recommended articles:
Modern principles of therapy for patients with spinal muscular atro­phy. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(3):34-40
Medi­cal reha­bilitation of patients with spinal muscular atro­phy. Problems of Balneology, Physiotherapy and Exercise Therapy. 2023;(2):5-13
Postviral rhinosinusitis, focus on pathogenetic therapy. Russian Bulletin of Otorhinolaryngology. 2023;(3):38-43
Fede­ral Clinical Guidelines on Vaccination of pneumococcal infe­ction in children and adults. Russian Journal of Preventive Medi­cine and Public Health. 2023;(9-2):3-23
Case of Langerhans cell multisystem histiocytosis with lesions of skin and visceral organs. Russian Journal of Clinical Dermatology and Vene­reology. 2023;(6):669-674
Risdiplam for the treatment of spinal muscular atro­phy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(2):45-57

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.